|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 5 1569-R1571, Copyright © 1997 by American Physiological Society
ARTICLES |
D. J. Reis and J. E. Piletz
Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021, USA.
Clonidine, moxonidine, and rilmenidine are centrally acting antihypertensive agents that lower arterial pressure by inhibiting the tonic activity of sympathoexcitatory neurons in the rostral ventrolateral medulla. Competing hypotheses have been put forward by different investigators to explain the sympathoinhibition evoked by "imidazoline drugs": either via central actions at alpha 2-adrenergic receptors or novel I1-imidazoline receptors. These different perspectives are presented in the accompanying reviews.
This article has been cited by other articles:
![]() |
M. Philipp, M. Brede, and L. Hein Physiological significance of alpha 2-adrenergic receptor subtype diversity: one receptor is not enough Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R287 - R295. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamazato, A. Sakima, J. Nakazato, S. Sesoko, H. Muratani, and K. Fukiyama Hypotensive and sedative effects of clonidine injected into the rostral ventrolateral medulla of conscious rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1868 - R1876. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |